Copeland's Dickson buy adds cloud-native monitoring as the pharma cold chain moves toward continuous visibility to meet rising regulatory demands.
Publication|Articles|December 8, 2023
- Pharmaceutical Commerce - December 2023
- Volume 18
- Issue 6
Pharmaceutical Commerce - December 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce December 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 3 years ago
Patients are the Priorityalmost 3 years ago
Brand Evolution and Engagementalmost 3 years ago
A Supply Chain Overhaulalmost 3 years ago
Continued Affordability Challenges in the Offingalmost 3 years ago
Who Moved My Prescription?almost 3 years ago
Transforming the Patient Hub into a Hub of Patient Centricityalmost 3 years ago
Navigating the Biosimilars Marketplacealmost 3 years ago
An Outlook on Data-Powered Patient Supportalmost 3 years ago
Prescribing Resilience: Third-Party Risks and Pharmaalmost 3 years ago
The Business Case for RWEAdvertisement
Related to this article
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Episode 3 of Supply Chain Signal examines the Aug. 31 MFN agreements with nine mid-size manufacturers, the GENEROUS Medicaid model and whether pricing, trade and manufacturing policy now add up to a new pharma operating model.
Cencora's Ameer Ali on the operational lift behind the 12-digit NDC shift, the readiness gap across manufacturers and what's at stake for product flow if systems aren't ready in time.
Temperature excursions cost pharma an estimated $35 billion a year as biologics, GLP-1s and cell and gene therapies raise cold chain stakes.
Valerie Bandy of Tecsys on where 340B rebate mechanics threaten pharmacy purchasing, and how stakeholders can prevent disruption.
CMS says 40 states and Puerto Rico have signed on to the GENEROUS Model, which applies MFN pricing to Medicaid drugs through state-invoiced rebates.
Informa's invitation-only Leadership Summit returns to CPHI Milan Oct. 6 as executives weigh sourcing, medicine security and reshoring pressure.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FAQ: How the GENEROUS Model Applies MFN Pricing to Medicaid
2
Why Temperature Control Is Now Pharma’s Make-or-Break Variable
3
Supply Chain Signal: How Policy Pressures Are Converging on Pharma
4
Pharma Pulse: Vicapsys-Stateline Merger and Veritiv's TempSafe RxShield
5